Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip

Clinical trial NCT02447276 · COMPLETED

Trial details

NCT number: NCT02447276
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Osteoarthritis, Knee Osteoarthritis, Hip

Start date: 2015-05-01
Primary completion: 2016-03-01
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.